Two Sigma Advisers LP lifted its position in CVS Health Co. (NYSE:CVS - Free Report) by 88.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,100,700 shares of the pharmacy operator's stock after purchasing an additional 987,100 shares during the period. Two Sigma Advisers LP owned 0.17% of CVS Health worth $132,092,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. CX Institutional lifted its stake in CVS Health by 38.3% in the second quarter. CX Institutional now owns 9,350 shares of the pharmacy operator's stock worth $552,000 after acquiring an additional 2,589 shares during the period. Wolff Wiese Magana LLC boosted its stake in shares of CVS Health by 18.9% during the second quarter. Wolff Wiese Magana LLC now owns 1,429 shares of the pharmacy operator's stock valued at $84,000 after purchasing an additional 227 shares in the last quarter. Gateway Investment Advisers LLC increased its holdings in CVS Health by 1.1% during the second quarter. Gateway Investment Advisers LLC now owns 368,895 shares of the pharmacy operator's stock valued at $21,787,000 after buying an additional 3,900 shares during the period. Alterna Wealth Management Inc. lifted its holdings in CVS Health by 7.8% during the second quarter. Alterna Wealth Management Inc. now owns 10,645 shares of the pharmacy operator's stock worth $629,000 after buying an additional 772 shares during the period. Finally, Oak Asset Management LLC boosted its position in CVS Health by 0.8% during the 2nd quarter. Oak Asset Management LLC now owns 84,672 shares of the pharmacy operator's stock valued at $5,001,000 after acquiring an additional 644 shares in the last quarter. Institutional investors own 80.66% of the company's stock.
Wall Street Analysts Forecast Growth
CVS has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a research note on Tuesday. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research report on Thursday, October 24th. Cantor Fitzgerald reissued a "neutral" rating and set a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Evercore ISI lifted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $70.50.
View Our Latest Stock Report on CVS Health
CVS Health Price Performance
NYSE CVS traded down $1.41 on Friday, hitting $55.45. The company had a trading volume of 6,295,137 shares, compared to its average volume of 11,259,884. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market capitalization of $69.78 billion, a PE ratio of 14.15, a PEG ratio of 1.01 and a beta of 0.54. CVS Health Co. has a 12-month low of $52.71 and a 12-month high of $83.25. The company's fifty day moving average price is $59.39 and its 200-day moving average price is $58.79.
CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the firm earned $2.21 EPS. The company's revenue for the quarter was up 6.3% on a year-over-year basis. As a group, analysts predict that CVS Health Co. will post 5.37 earnings per share for the current year.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.80%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's dividend payout ratio (DPR) is 67.51%.
About CVS Health
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
